Survival analysis for AdVerse events with VarYing follow-up times (SAVVY): summary of findings and a roadmap for the future of safety analyses in clinical trials
Fuente:
arXiv
Guardado en:
| Autores principales: | Rufibach, Kaspar, Beyersmann, Jan, Friede, Tim, Schmoor, Claudia, Stegherr, Regina |
|---|---|
| Formato: | Preprint |
| Publicado: |
2024
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
Oncology Clinical Trial Design Planning Based on a Multistate Model That Jointly Models Progression‐Free and Overall Survival Endpoints
por: Alexandra Erdmann, et al.
Publicado: (2024)
por: Alexandra Erdmann, et al.
Publicado: (2024)
Exhausting the type I error level in event-driven group-sequential designs with a closed testing procedure for progression-free and overall survival
por: Danzer, Moritz Fabian, et al.
Publicado: (2025)
por: Danzer, Moritz Fabian, et al.
Publicado: (2025)
Using shrinkage methods to estimate treatment effects in overlapping subgroups in randomized clinical trials with a time-to-event endpoint
por: Wolbers, Marcel, et al.
Publicado: (2024)
por: Wolbers, Marcel, et al.
Publicado: (2024)
Balancing events, not patients, maximizes power of the logrank test: and other insights on unequal randomization in survival trials
por: Yung, Godwin, et al.
Publicado: (2024)
por: Yung, Godwin, et al.
Publicado: (2024)
Landmarking for Left‐Truncated Competing Risk Data
por: Theresa Unseld, et al.
Publicado: (2024)
por: Theresa Unseld, et al.
Publicado: (2024)
"6 choose 4": A framework to understand and facilitate discussion of strategies for overall survival safety monitoring
por: Yung, Godwin, et al.
Publicado: (2024)
por: Yung, Godwin, et al.
Publicado: (2024)
Balancing Events, Not Patients, Maximizes Power of the Logrank Test: And Other Insights on Unequal Randomization in Survival Trials
por: Godwin Yung, et al.
Publicado: (2025)
por: Godwin Yung, et al.
Publicado: (2025)
Clinical trials with interim analyses: Standardizing Terminology to increase clarity
por: Asikanius, Elina, et al.
Publicado: (2024)
por: Asikanius, Elina, et al.
Publicado: (2024)
Das Russinische
por: Stegherr, Marc
Publicado: (2019)
por: Stegherr, Marc
Publicado: (2019)
Comparing restricted mean survival times in small sample clinical trials using pseudo-observations
por: Jesse, David, et al.
Publicado: (2024)
por: Jesse, David, et al.
Publicado: (2024)
Getting SAVVY: A Database for Reference Use.
por: Anderson, Charles
Publicado: (1986)
por: Anderson, Charles
Publicado: (1986)
Bayesian random-effects meta-analysis of aggregate data on clinical events
por: Röver, Christian, et al.
Publicado: (2025)
por: Röver, Christian, et al.
Publicado: (2025)
Refining the paradigm in urinary diversion: the MOSAIC trial and roadmap for future innovation
por: DuJiang Yang, et al.
Publicado: (2025)
por: DuJiang Yang, et al.
Publicado: (2025)
The emerging clinical relevance of Enterococcus gallinarum: A roadmap for future research and diagnostics.
por: Hyderi, Zeeshan, et al.
Publicado: (2026)
por: Hyderi, Zeeshan, et al.
Publicado: (2026)
National roadmap for health and safety of fishery products
por: Ghoroghi, Ahmad, et al.
Publicado: (2015)
por: Ghoroghi, Ahmad, et al.
Publicado: (2015)
Effectiveness of residential versus outpatient therapy for smoking cessation: The START randomized clinical trial
por: Jonas Levin Dickreuter, et al.
Publicado: (2024)
por: Jonas Levin Dickreuter, et al.
Publicado: (2024)
Let's Think Var-by-Var: Large Language Models Enable Ad Hoc Probabilistic Reasoning
por: Xia, Shepard, et al.
Publicado: (2024)
por: Xia, Shepard, et al.
Publicado: (2024)
SAVVY: Spatial Awareness via Audio-Visual LLMs through Seeing and Hearing
por: Chen, Mingfei, et al.
Publicado: (2025)
por: Chen, Mingfei, et al.
Publicado: (2025)
Blinded sample size re-estimation accounting for uncertainty in mid-trial estimation
por: Maeda, Hirotada, et al.
Publicado: (2026)
por: Maeda, Hirotada, et al.
Publicado: (2026)
Reimagining the future of cancer clinical trials
por: Bryn Nelson, et al.
Publicado: (2024)
por: Bryn Nelson, et al.
Publicado: (2024)
Brain energy metabolism: A roadmap for future research
por: Caroline D. Rae, et al.
Publicado: (2024)
por: Caroline D. Rae, et al.
Publicado: (2024)
Communicating results in trials with multiple hypotheses or adaptive design features
por: Asikanius, Elina, et al.
Publicado: (2026)
por: Asikanius, Elina, et al.
Publicado: (2026)
Comment on Ying Ye et al.
por: Wei Zhang, et al.
Publicado: (2025)
por: Wei Zhang, et al.
Publicado: (2025)
Data mining in occupational safety and health: a systematic mapping and roadmap
por: Beatriz Lavezo dos Reis
Publicado: (2021)
por: Beatriz Lavezo dos Reis
Publicado: (2021)
Incorporating estimands into meta-analyses of clinical trials
por: Remiro-Azócar, Antonio, et al.
Publicado: (2025)
por: Remiro-Azócar, Antonio, et al.
Publicado: (2025)
Piecewise Constant Hazard Estimation with the Fused Lasso
por: Rosenbaum, Manuel, et al.
Publicado: (2024)
por: Rosenbaum, Manuel, et al.
Publicado: (2024)
Reply to Dr. Yingli Lin et al.
por: Xiaolan Zhang, et al.
Publicado: (2025)
por: Xiaolan Zhang, et al.
Publicado: (2025)
Picture of the Month by Jushuo Wang and Yingli Fan
Publicado: (2025)
Publicado: (2025)
Picture of the Month by Jushuo Wang and Yingli Fan
Publicado: (2025)
Publicado: (2025)
Estimand framework and intercurrent events handling for clinical trials with time-to-event outcomes
por: Fang, Yixin, et al.
Publicado: (2025)
por: Fang, Yixin, et al.
Publicado: (2025)
Controlled Loss of Control: The Articulation of Resilience as ‘Empty Signifier’ in EU and NATO Policies
por: Alexandra M. Friede
Publicado: (2025)
por: Alexandra M. Friede
Publicado: (2025)
Evaluation of 3D‐Var and 4D‐Var data assimilation on simulation of heavy rainfall events over the Indian region
por: Shivaji S. Patel, et al.
Publicado: (2025)
por: Shivaji S. Patel, et al.
Publicado: (2025)
One‐year anthropometric follow‐up of South African preterm infants in kangaroo mother care: Which early‐life factors predict malnutrition?
por: Sanja Nel, et al.
Publicado: (2024)
por: Sanja Nel, et al.
Publicado: (2024)
Adverse immunostimulation in early phase clinical trials: Key findings and recommendations based on the investigator's clinical experience
por: Juliette A. van den Noort, et al.
Publicado: (2025)
por: Juliette A. van den Noort, et al.
Publicado: (2025)
The future of digital pills and their potential use in dermatological clinical trials
por: Liana Victory, et al.
Publicado: (2024)
por: Liana Victory, et al.
Publicado: (2024)
Women’s involvement in clinical trials: historical perspective and future implications
por: Katherine A. LIU
Publicado: (2016)
por: Katherine A. LIU
Publicado: (2016)
Overview of Alzheimer's Disease Neuroimaging Initiative and future clinical trials
por: Michael W. Weiner, et al.
Publicado: (2024)
por: Michael W. Weiner, et al.
Publicado: (2024)
Event-driven type design for clinical trials with recurrent events
por: Zhang, Jingwen, et al.
Publicado: (2026)
por: Zhang, Jingwen, et al.
Publicado: (2026)
Characteristics of suitable cases for treatment with nemolizumab based on clinical findings and cutaneous adverse events
por: Akiko Sugiyama, et al.
Publicado: (2025)
por: Akiko Sugiyama, et al.
Publicado: (2025)
Assessing safety and efficacy in subpopulations in Alzheimer's disease clinical trials: contextualizing representativeness
por: Guogen Shan, et al.
Publicado: (2025)
por: Guogen Shan, et al.
Publicado: (2025)
Ejemplares similares
-
Oncology Clinical Trial Design Planning Based on a Multistate Model That Jointly Models Progression‐Free and Overall Survival Endpoints
por: Alexandra Erdmann, et al.
Publicado: (2024) -
Exhausting the type I error level in event-driven group-sequential designs with a closed testing procedure for progression-free and overall survival
por: Danzer, Moritz Fabian, et al.
Publicado: (2025) -
Using shrinkage methods to estimate treatment effects in overlapping subgroups in randomized clinical trials with a time-to-event endpoint
por: Wolbers, Marcel, et al.
Publicado: (2024) -
Balancing events, not patients, maximizes power of the logrank test: and other insights on unequal randomization in survival trials
por: Yung, Godwin, et al.
Publicado: (2024) -
Landmarking for Left‐Truncated Competing Risk Data
por: Theresa Unseld, et al.
Publicado: (2024)